ýMV

Expanded list of eligible conditions for medical cannabis

June 6, 2023

gsc update

As you may recall, in March 2018, ýMV launched a medical cannabis (MC) product offering more options for incorporating MC into a benefits plan, but with much greater oversight and rigour than is currently available through a health care spending account (HCSA). The landscape continues to evolve, and since launch, we have conducted regular reviews of the emerging evidence and, based on a recent review of the best available research, our MC product currently includes the following medical conditions (as a last resort treatment option):

  • Chronic neuropathic pain in adults aged 25 and older
  • Spasticity due to multiple sclerosis in adults aged 25 and older
  • Nausea and vomiting due to cancer chemotherapy in adults aged 25 and older
  • Seizures in those age two and older diagnosed with Dravet syndrome or Lennox-Gastaut syndrome (CBD products only)
  • Palliative cancer pain in adults aged 18 and older

Adding this optional MC benefit to your plan provides a much more fluid and adaptive option compared to an HCSA. Contact your account team for more information.

Read more

Cares
No One Told Me It’d Be Like Dating: Finding the Right Therapist

Don't let the fear of asking for help hold you back. Book your free therapy session today and take control of your mental health. Discover the power of therapy and find the support you need to thrive.

Health
What is an Employee Assistance Program (EAP)?

Learn about an Employee Assistance Program (EAP) and why it’s essential for HR leaders to support employee well-being, retention, and recruitment.

Cares
Celebrate and learn about the history and culture of First Nations, Metis and Inuit peoples this National Indigenous History Mon

Celebrate National Indigenous History Month with GSC! Join us in reflecting on Canada's Indigenous peoples' history, supporting Indigenous businesses, and promoting mutual respect and shared prosperity.

View all